semaglutide arrhythmia A Shocking Case of Semaglutide-Induced Ventricular Arrhythmia

Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications

20.85

★★★★☆4.8 (126)

Abstract 4368472: Glucagon-Like Peptide 1 Mediated Reduction in Atrial Fibrillation Risk Is Independent of Weight Loss

20.22

★★★★★4.9 (98)

Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization | Diabetology & Metabolic Syndrome

27.31

★★★★★5.0 (157)

Effect of semaglutide on arrhythmic, major cardiovascular, and renal outcomes in patients with overweight or obesity: a systematic review and meta-analysis | European Journal of Medical Research

20.23

★★★★★4.7 (84)

Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes

24.35

★★★★★4.9 (203)

In a 68-year-old obese male (BMI ~36) with a history of atrial fibrillation controlled by two ablations, a permanent pacemaker, a Watchman left‑atrial appendage closure device, chronic obstructive pulmonary disease, and chronic

29.95

★★★★★5.0 (176)

Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation: PRAGUE-25 Trial

28.30

★★★★★4.8 (132)